Open source biotechnology: A drug for developing countries' health problems?

    Research output: Book/ReportReportProfessional

    Abstract

    In developing countries, many people suffer from diseases for which there are no drugs or for which drugs exist that they cannot afford because they are too expensive. The advent of genomics has sparked the idea that new drugs can be more easily developed and that genomics thus could lessen the health problems prevalent in developing countries. Until now, genomics has not been able to realise that promise. This paper explores whether, and if so, how open source biotechnology (hereinafter: OSB) can stimulate medical drug development specifically targeted at the health problems of developing countries.
    Original languageEnglish
    Place of Publicationonbekend
    PublisherTilburg Institute for Law Technology and Society
    Publication statusPublished - 2008

    Fingerprint

    biotechnology
    developing country
    drug
    health
    Disease

    Cite this

    Schellekens, M. H. M. (2008). Open source biotechnology: A drug for developing countries' health problems? onbekend: Tilburg Institute for Law Technology and Society.
    Schellekens, M.H.M. / Open source biotechnology : A drug for developing countries' health problems?. onbekend : Tilburg Institute for Law Technology and Society, 2008.
    @book{d3fefbc47eb34a999249712599110b30,
    title = "Open source biotechnology: A drug for developing countries' health problems?",
    abstract = "In developing countries, many people suffer from diseases for which there are no drugs or for which drugs exist that they cannot afford because they are too expensive. The advent of genomics has sparked the idea that new drugs can be more easily developed and that genomics thus could lessen the health problems prevalent in developing countries. Until now, genomics has not been able to realise that promise. This paper explores whether, and if so, how open source biotechnology (hereinafter: OSB) can stimulate medical drug development specifically targeted at the health problems of developing countries.",
    author = "M.H.M. Schellekens",
    year = "2008",
    language = "English",
    publisher = "Tilburg Institute for Law Technology and Society",

    }

    Schellekens, MHM 2008, Open source biotechnology: A drug for developing countries' health problems? Tilburg Institute for Law Technology and Society, onbekend.

    Open source biotechnology : A drug for developing countries' health problems? / Schellekens, M.H.M.

    onbekend : Tilburg Institute for Law Technology and Society, 2008.

    Research output: Book/ReportReportProfessional

    TY - BOOK

    T1 - Open source biotechnology

    T2 - A drug for developing countries' health problems?

    AU - Schellekens, M.H.M.

    PY - 2008

    Y1 - 2008

    N2 - In developing countries, many people suffer from diseases for which there are no drugs or for which drugs exist that they cannot afford because they are too expensive. The advent of genomics has sparked the idea that new drugs can be more easily developed and that genomics thus could lessen the health problems prevalent in developing countries. Until now, genomics has not been able to realise that promise. This paper explores whether, and if so, how open source biotechnology (hereinafter: OSB) can stimulate medical drug development specifically targeted at the health problems of developing countries.

    AB - In developing countries, many people suffer from diseases for which there are no drugs or for which drugs exist that they cannot afford because they are too expensive. The advent of genomics has sparked the idea that new drugs can be more easily developed and that genomics thus could lessen the health problems prevalent in developing countries. Until now, genomics has not been able to realise that promise. This paper explores whether, and if so, how open source biotechnology (hereinafter: OSB) can stimulate medical drug development specifically targeted at the health problems of developing countries.

    M3 - Report

    BT - Open source biotechnology

    PB - Tilburg Institute for Law Technology and Society

    CY - onbekend

    ER -

    Schellekens MHM. Open source biotechnology: A drug for developing countries' health problems? onbekend: Tilburg Institute for Law Technology and Society, 2008.